Literature DB >> 27072507

Central & peripheral glucagon-like peptide-1 receptor signaling differentially regulate addictive behaviors.

Sunil Sirohi1, Jennifer D Schurdak2, Randy J Seeley3, Stephen C Benoit2, Jon F Davis4.   

Abstract

Recent data implicate glucagon-like peptide-1 (GLP-1), a potent anorexigenic peptide released in response to nutrient intake, as a regulator for the reinforcing properties of food, alcohol and psychostimulants. While, both central and peripheral mechanisms mediate effects of GLP-1R signaling on food intake, the extent to which central or peripheral GLP-1R signaling regulates reinforcing properties of drugs of abuse is unknown. Here, we examined amphetamine reinforcement, alcohol intake and hedonic feeding following peripheral administration of EX-4 (a GLP-1 analog) in FLOX and GLP-1R KD(Nestin) (GLP-1R selectively ablated from the central nervous system) mice (n=13/group). First, the effect of EX-4 pretreatment on the expression of amphetamine-induced conditioned place preference (Amp-CPP) was examined in the FLOX and GLP-1R KD(Nestin) mice. Next, alcohol intake (10% v/v) was evaluated in FLOX and GLP-1R KD(Nestin) mice following saline or EX-4 injections. Finally, we assessed the effects of EX-4 pretreatment on hedonic feeding behavior. Results indicate that Amp-CPP was completely blocked in the FLOX mice, but not in the GLP-1R KD(Nestin) mice following EX-4 pretreatment. Ex-4 pretreatment selectively blocked alcohol consumption in the FLOX mice, but was ineffective in altering alcohol intake in the GLP-1R KD(Nestin) mice. Notably, hedonic feeding was partially blocked in the GLP-1R KD(Nestin) mice, whereas it was abolished in the FLOX mice. The present study provides critical insights regarding the nature by which GLP-1 signaling controls reinforced behaviors and underscores the importance of both peripheral and central GLP-1R signaling for the regulation of addictive disorders.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Alcohol intake; Amphetamine reinforcement; GLP-1; GLP-1R; Hedonic feeding

Mesh:

Substances:

Year:  2016        PMID: 27072507     DOI: 10.1016/j.physbeh.2016.04.013

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  15 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review.

Authors:  Amanda Brunchmann; Morgane Thomsen; Anders Fink-Jensen
Journal:  Physiol Behav       Date:  2019-04-01

3.  Behavioral and Neurobiological Consequences of Hedonic Feeding on Alcohol Drinking.

Authors:  Julianna Brutman; Jon F Davis; Sunil Sirohi
Journal:  Curr Pharm Des       Date:  2020       Impact factor: 3.116

Review 4.  The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.

Authors:  Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink-Jensen
Journal:  Br J Pharmacol       Date:  2022-02       Impact factor: 9.473

5.  Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice.

Authors:  Gunnar Sørensen; S Barak Caine; Morgane Thomsen
Journal:  Alcohol Clin Exp Res       Date:  2016-08-31       Impact factor: 3.455

6.  A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.

Authors:  Yafang Zhang; Suditi Rahematpura; Kael H Ragnini; Amanda Moreno; Kamryn S Stecyk; Michelle W Kahng; Brandon T Milliken; Matthew R Hayes; Robert P Doyle; Heath D Schmidt
Journal:  Neuropharmacology       Date:  2021-05-11       Impact factor: 5.273

Review 7.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

Review 8.  Parallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons.

Authors:  Ted M Hsu; James E McCutcheon; Mitchell F Roitman
Journal:  Front Psychiatry       Date:  2018-09-03       Impact factor: 4.157

Review 9.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

10.  Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.

Authors:  Annika Billefeld Bornebusch; Anders Fink-Jensen; Gitta Wörtwein; Randy J Seeley; Morgane Thomsen
Journal:  eNeuro       Date:  2019-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.